@misc{indiciae84078f2c5616,
  title = {Therapeutic targeting of immunometabolism in Alzheimers disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression.},
  author = {Codocedo, J. F. and Mera Reina, C. and Lin, P. B.-C. and Puntambekar, S. S. and Casali, B. T. and Jury, N. and Martinez, P. and Lasagna-Reeves, C. A. and Landreth, G. E.},
  year = {2023},
  doi = {10.1101/2023.11.11.566270},
  url = {https://www.biorxiv.org/content/10.1101/2023.11.11.566270v1},
  note = {Source identifier: 10.1101/2023.11.11.566270}
}